Correlation Between NervGen Pharma and Arch Biopartners
Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NervGen Pharma Corp and Arch Biopartners, you can compare the effects of market volatilities on NervGen Pharma and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and Arch Biopartners.
Diversification Opportunities for NervGen Pharma and Arch Biopartners
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NervGen and Arch is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and Arch Biopartners go up and down completely randomly.
Pair Corralation between NervGen Pharma and Arch Biopartners
Assuming the 90 days trading horizon NervGen Pharma Corp is expected to generate 1.48 times more return on investment than Arch Biopartners. However, NervGen Pharma is 1.48 times more volatile than Arch Biopartners. It trades about 0.05 of its potential returns per unit of risk. Arch Biopartners is currently generating about 0.02 per unit of risk. If you would invest 170.00 in NervGen Pharma Corp on August 31, 2024 and sell it today you would earn a total of 117.00 from holding NervGen Pharma Corp or generate 68.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NervGen Pharma Corp vs. Arch Biopartners
Performance |
| Timeline |
| NervGen Pharma Corp |
| Arch Biopartners |
NervGen Pharma and Arch Biopartners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NervGen Pharma and Arch Biopartners
The main advantage of trading using opposite NervGen Pharma and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.| NervGen Pharma vs. NervGen Pharma Corp | NervGen Pharma vs. Medicenna Therapeutics Corp | NervGen Pharma vs. Arch Biopartners | NervGen Pharma vs. Sirona Biochem Corp |
| Arch Biopartners vs. NervGen Pharma Corp | Arch Biopartners vs. Nanalysis Scientific Corp | Arch Biopartners vs. Perimeter Medical Imaging | Arch Biopartners vs. Medicenna Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |